BORTEZOMIB
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- BORTEZOMIB
- Generic name
- BORTEZOMIB
- Manufacturer
- Zydus Lifesciences Limited
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 582c7c0d-fa25-4586-8157-a1e2653d72d9
- SPL ID
- a7ff2205-566b-4fb5-8f33-bf73377ee093
- Version
- 1
- Effective date
- 2022-05-05
- Source export date
- 2026-10-12
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:39:59
| Harmonized routes |
|---|
| INTRAVENOUS, SUBCUTANEOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 210204 | derived:openfda.application_number |
| application number | ANDA210204 | openfda.application_number | |
| brand name | BORTEZOMIB | openfda.brand_name | |
| generic name | BORTEZOMIB | openfda.generic_name | |
| manufacturer name | Zydus Lifesciences Limited | openfda.manufacturer_name | |
| ndc | package | 70771-1708-1 | openfda.package_ndc |
| ndc | product | 70771-1708 | openfda.product_ndc |
| ndc11 | package | 70771170801 | derived:openfda.package_ndc |
| rxcui | 402243 | openfda.rxcui | |
| spl id | a7ff2205-566b-4fb5-8f33-bf73377ee093 | id | |
| spl set id | 582c7c0d-fa25-4586-8157-a1e2653d72d9 | set_id | |
| unii | 69G8BD63PP | openfda.unii |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.